entertainment -WSS

entertainment

author：entertainment 2025-09-30 00:08:49 - browse：363

A dosage of Wegovy, a drug used for weight loss — Amanda Andrade-Rhoades/AP

U.S. regulators approved a label expansion for Novo Nordisk’s obesity drug Wegovy to tout its benefits for the heart, a move that could boost demand and insurance coverage for the already highly popular treatment.

The new label indicates that Wegovy can be used to reduce the risk of major heart complications — including heart attack, stroke, or cardiovascular-related deaths — for people with overweight or obesity and existing heart disease, Novo said in a statement Friday.

The decision was based on results of a large, five-year trial that showed Wegovy cut the risk of cardiovascular problems by 20% in that population. This is the first time a weight loss treatment has been approved to also help improve heart outcomes, the FDA said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

WSS

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

What causes rare myocarditis in young men after Covid vaccines?

Woodcock on FDA’s accelerated approval and her next chapter

What to watch for from Zogenix and Amicus clinical trials

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

hotspot

entertainment

hotspot

In Memoriam: Notable people who died in 2023

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

Hepatitis C has a cure — but many Americans still lack access to it

Search called off for baby washed away in Pennsylvania flash flood

Medical leaders decry Supreme Court decision on affirmative action

UHS says company favors patients whose insurance pays more

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Commercial surrogacy can be ethical, despite pope’s claims

Activists slam private health insurers over coverage restrictions

Truvian presents data for its desktop blood

knowledge

Medicare drug price negotiation’s day in court

Dems pitch expanding Medicare power to negotiate drug prices

Cybersecurity threat forces Lurie Children's to take systems offline

ARCH Venture Partners is raising $3 billion for a life sciences fund

New Ultima Genomics DNA sequencer can read genome for $100

Do digital therapeutics have a future in medicine?

Wikipedia

leisure time

entertainment

focus